{"schema_version":"secwatch.filing_event.v1","accession":"0000917520-25-000014","form_type":"8-K","ticker":"IART","cik":"0000917520","company_name":"INTEGRA LIFESCIENCES HOLDINGS CORP","filed_at":"2025-02-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:06.798933+00:00","generated_at":"2026-05-26T05:20:18.848898+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Integra LifeSciences Q4 adj EPS $0.97 (+9% YoY); FY24 GAAP EPS ($0.09); 2025 adj EPS guidance $2.41-$2.51","bullets":["Q4 2024: rev $442.6M (+11.5% rep, +3.5% org); adj EPS $0.97 vs $0.89; GAAP EPS $0.25 flat YoY.","FY2024: rev $1,610.5M (+4.5% rep, -1.3% org); GAAP EPS ($0.09) vs $0.84; adj EPS $2.56 vs $3.10.","FY2025 guidance: rev $1,650M-$1,715M (+2.4-6.5% rep, +1.0-5.0% org); adj EPS $2.41-$2.51 (below 2024 adj EPS $2.56).","Q1 2025 guidance: rev $375M-$385M (+1.6-4.4% rep); org rev -6.2% to -3.5% due to ship holds & Integra Skin delays.","Net debt $1.5B; leverage ratio 4.0x; FY2024 cash from ops $129.4M, capex $104.0M."],"urls":{"canonical":"https://secwatch.observer/filing/0000917520-25-000014","json":"https://secwatch.observer/filing/0000917520-25-000014.json","markdown":"https://secwatch.observer/filing/0000917520-25-000014.md","text":"https://secwatch.observer/filing/0000917520-25-000014.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000014/0000917520-25-000014-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/917520/000091752025000014/iart-20250225.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T05:20:18.848898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}